NCT01772602 The National Amyotrophic Lateral Sclerosis Registry
| NCT ID | NCT01772602 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centers for Disease Control and Prevention |
| Condition | Amyotrophic Lateral Sclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 30,000 participants |
| Start Date | 2010-10 |
| Primary Completion | 2040-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30,000 participants in total. It began in 2010-10 with a primary completion date of 2040-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this registry is to (A) better describe the incidence and prevalence of Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors, such as environmental and occupational, that may be associated with the disease; (C) better outline key demographic factors (such as age, race or ethnicity, gender, and family history of individuals who are diagnosed with the disease) associated with the disease; and (D) better examine the connection between ALS and other motor neuron disorders that can be confused with ALS, misdiagnosed as ALS, and in some cases progress to ALS.
Eligibility Criteria
Inclusion Criteria: \- U.S. citizens 18 years of age or older Exclusion Criteria: \-
Contact & Investigator
Paul Mehta, MD
PRINCIPAL INVESTIGATOR
Centers for Disease Control and Prevention
Frequently Asked Questions
Who can join the NCT01772602 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Amyotrophic Lateral Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01772602 currently recruiting?
Yes, NCT01772602 is actively recruiting participants. Contact the research team at PMehta1@cdc.gov for enrollment information.
Where is the NCT01772602 trial being conducted?
This trial is being conducted at Atlanta, United States.
Who is sponsoring the NCT01772602 clinical trial?
NCT01772602 is sponsored by Centers for Disease Control and Prevention. The principal investigator is Paul Mehta, MD at Centers for Disease Control and Prevention. The trial plans to enroll 30,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.